혈청 항기저막 항체검사에서 위양성을 보인 막증식성 사구체신염 1예 = Case Report : A Case of Membranoproliferative Glomerulonephritis with False-Positive Reaction for Anti-GBM Antibody

다국어 초록 (Multilingual Abstract)

Anti-glomerular basement membrane (Anti-GBM) nephritis is an autoimmune disorder characterized by rapidly progressive crescentic glomerulonephritis (RPGN). The treatment of anti-GBM nephritis with plasmapheresis, steroids and immunosuppressant has improved outcomes. An early diagnosis is essential for the survival of patients and a recovery of renal function. The diagnosis of anti-GBM disease has been traditionally based on the demonstration of linear deposits of immunoglobulins along the glomerular basement membrane by immunofluorescence (IF) microscopy. However, a kidney biopsy cannot always be easily performed in such ill patients. Recent development of specific enzyme immunoassays for anti-GBM antibody in the serum has made possible a provisional diagnosis without a kidney biopsy. A 46-year-old male patient with hypertension and hepatitis B presented with generalized edema and general weakness. Laboratory findings were compatible with acute renal failure and nephritic syndrome with positive serum anti-GBM antibodies. After plasmapheresis with steroid pulse therapy, renal biopsy was performed and diagnosed as membranoproliferative glomerulonephritis (MPGN) with granular deposit of Ig G and C3. Follow-up antibody titers were negative. This case demonstrates the possibility of false-positive anti-GBM antibody in the serum. Therefore, enzyme immunoassay for anti-GBM antibody should be used only as a screening or follow-up test in patients that have been confirmed positive by IF microscopy.

참고문헌 (Reference)

1 Booth Ronald A., "Sawchyn Marjetka: Case report: Pitfalls of false positive anti-GBM antibody ELISA results" 41 : 1264-, 2008

2 Borza DB, "Molecular characterization of the target antigens of anti-glomerular basement membrane antibody disease" 24 : 345-361, 2003

3 Kalluri R, "Identification of the alpha 3 chain of type IV collagen as the common autoantigen in antibasement membrane disease and goodpasture syndrome" 6 : 1178-1185, 1995

4 Hellmark T, "Epitope mapping of anti-glomerular basement membrane (GBM) antibodies with synthetic peptides" 105 : 504-510, 1996

5 DeAangelo AJ, "Diabetic nephropathy with interstitial nephritis presenting with a false-positive anti-GBM antibody" 57 : 381-385, 2002

6 Mahieu P, "Detection of anti-glomerular basement membrane antibodies by radioimmunological technique. clinical application in human nephropathies" 54 : 128-137, 1974

7 Jaskowski TD, "Comparison of four enzyme immunoassays for the detection of immunoglobulin G antibody against glomerular basement membrane" 16 : 143-145, 2002

8 Cui Z, "Avidity of anti-glomerular basement membrane autoantibodies was associated with disease severity" 116 : 77-82, 2005

9 Borza DB, "Autoepitopes and alloepitopes of type IV collagen: Role in the molecular pathogenesis of anti- GBM antibody glomerulonephritis" 106 : e37-e43, 2007

10 Turner AN, "Antibodies: Still important in anti-GBM disease" 94 : c51-c52, 2003

11 Sinico RA, "Anti-glomerular basement membrane antibodies in the diagnosis of Goodpasture syndrome: a comparison of different assays" 21 : 397-401, 2006

12 Hellmark T, "Anti-GBM antibodies in goodpasture syndrome; Anatomy of an epitope" 12 : 646-648, 1997

13 Hudson BG, "Alport’s Syndrome, Goodpasture’s Syndrome, and Type IV collagen" 348 : 2543-2556, 2003